Literature DB >> 17463088

GATA6 is an astrocytoma tumor suppressor gene identified by gene trapping of mouse glioma model.

Deepak Kamnasaran1, Baoping Qian, Cynthia Hawkins, William L Stanford, Abhijit Guha.   

Abstract

Malignant astrocytomas are the most common and lethal adult primary brain tumor. Retroviral gene trapping of nontransformed neonatal astrocytes from a glial fibrillary acidic protein (GFAP):(V12)Ha-Ras murine astrocytoma model led to isolation of the transcription factor Gata6. Loss of Gata6 resulted in enhanced proliferation and transformation of astrocytes. Human malignant astrocytoma cell lines, explant xenografts, and operative specimens demonstrated loss of GATA6 expression. Loss-of-function GATA6 mutations with loss of heterozygosity of the GATA6 locus were found in human malignant astrocytoma specimens but not in lower-grade astrocytomas or normal adult astrocytes. Knockdown of Gata6 expression in (V12)Ha-Ras or p53-/- astrocytes, but not in parental murine or human astrocytes, led to acceleration of tumorgenesis. Knockin GATA6 expression in human malignant astrocytoma cells reduced their tumorgenic growth with decreased VEGF expression. Collectively, these data demonstrate that GATA6, isolated from a murine astrocytoma model, is a novel tumor suppressor gene that is a direct target of mutations during malignant progression of murine and human astrocytomas. This work also demonstrates the utility of random mutagenesis strategies, such as gene trapping, on murine cancer models toward discovery of novel genetic alterations in corresponding human cancers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17463088      PMCID: PMC1876570          DOI: 10.1073/pnas.0611669104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus.

Authors:  G Chenevix-Trench; J Leary; J Kerr; J Michel; R Kefford; T Hurst; P G Parsons; M Friedlander; S K Khoo
Journal:  Oncogene       Date:  1992-06       Impact factor: 9.867

2.  GATA-6 induces p21(Cip1) expression and G1 cell cycle arrest.

Authors:  H Perlman; E Suzuki; M Simonson; R C Smith; K Walsh
Journal:  J Biol Chem       Date:  1998-05-29       Impact factor: 5.157

3.  Frequent loss of heterozygosity on chromosome arm 18q in squamous cell carcinomas. Identification of 2 regions of loss--18q11.1-q12.3 and 18q21.1-q23.

Authors:  J W Jones; J R Raval; T F Beals; M J Worsham; D L Van Dyke; R M Esclamado; G T Wolf; C R Bradford; T Miller; T E Carey
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1997-06

4.  National survey of patterns of care for brain-tumor patients.

Authors:  M S Mahaley; C Mettlin; N Natarajan; E R Laws; B B Peace
Journal:  J Neurosurg       Date:  1989-12       Impact factor: 5.115

5.  Proliferation of human malignant astrocytomas is dependent on Ras activation.

Authors:  A Guha; M M Feldkamp; N Lau; G Boss; A Pawson
Journal:  Oncogene       Date:  1997-12-04       Impact factor: 9.867

6.  Targeted disruption of the mouse ELYS gene results in embryonic death at peri-implantation development.

Authors:  Keisuke Okita; Hiroshi Kiyonari; Ikuo Nobuhisa; Naoki Kimura; Shinichi Aizawa; Tetsuya Taga
Journal:  Genes Cells       Date:  2004-11       Impact factor: 1.891

7.  Microarray analysis of temporal gene responses to ionizing radiation in two glioblastoma cell lines: up-regulation of DNA repair genes.

Authors:  Takashi Otomo; Makoto Hishii; Hajime Arai; Kiyoshi Sato; Keisuke Sasai
Journal:  J Radiat Res       Date:  2004-03       Impact factor: 2.724

Review 8.  A tiger behind many doors: multiple genetic pathways to malignant glioma.

Authors:  D N Louis; J F Gusella
Journal:  Trends Genet       Date:  1995-10       Impact factor: 11.639

9.  Genetic alterations in localized prostate cancer: identification of a common region of deletion on chromosome arm 18q.

Authors:  A Latil; J C Baron; O Cussenot; G Fournier; T Soussi; L Boccon-Gibod; A Le Duc; J Rouëssé; R Lidereau
Journal:  Genes Chromosomes Cancer       Date:  1994-10       Impact factor: 5.006

10.  GATA-4 and GATA-6 modulate tissue-specific transcription of the human gene for P450c17 by direct interaction with Sp1.

Authors:  Christa E Flück; Walter L Miller
Journal:  Mol Endocrinol       Date:  2004-02-26
View more
  33 in total

1.  GATA6 promotes colon cancer cell invasion by regulating urokinase plasminogen activator gene expression.

Authors:  Narasimhaswamy S Belaguli; Muhammad Aftab; Mohammed Rigi; Mao Zhang; Daniel Albo; David H Berger
Journal:  Neoplasia       Date:  2010-11       Impact factor: 5.715

2.  Trapping the mouse genome to hunt human alterations.

Authors:  Anne-Marie Bleau; Eric C Holland
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-03       Impact factor: 11.205

Review 3.  The neurobiology of gliomas: from cell biology to the development of therapeutic approaches.

Authors:  Manfred Westphal; Katrin Lamszus
Journal:  Nat Rev Neurosci       Date:  2011-08-03       Impact factor: 34.870

4.  Activation of GATA binding protein 6 (GATA6) sustains oncogenic lineage-survival in esophageal adenocarcinoma.

Authors:  Lin Lin; Adam J Bass; William W Lockwood; Zhuwen Wang; Amy L Silvers; Dafydd G Thomas; Andrew C Chang; Jules Lin; Mark B Orringer; Weiquan Li; Thomas W Glover; Thomas J Giordano; Wan L Lam; Matthew Meyerson; David G Beer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-28       Impact factor: 11.205

5.  Phosphorylation of the Hippo Pathway Component AMOTL2 by the mTORC2 Kinase Promotes YAP Signaling, Resulting in Enhanced Glioblastoma Growth and Invasiveness.

Authors:  Nicholas Artinian; Cheri Cloninger; Brent Holmes; Angelica Benavides-Serrato; Tariq Bashir; Joseph Gera
Journal:  J Biol Chem       Date:  2015-05-21       Impact factor: 5.157

6.  Src promotes GTPase activity of Ras via tyrosine 32 phosphorylation.

Authors:  Severa Bunda; Pardeep Heir; Tharan Srikumar; Jonathan D Cook; Kelly Burrell; Yoshihito Kano; Jeffrey E Lee; Gelareh Zadeh; Brian Raught; Michael Ohh
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

Review 7.  Lineage factors and differentiation states in lung cancer progression.

Authors:  W K C Cheung; D X Nguyen
Journal:  Oncogene       Date:  2015-03-30       Impact factor: 9.867

8.  The promoter hypermethylation status of GATA6, MGMT, and FHIT in glioblastoma.

Authors:  Gulsah Cecener; Berrin Tunca; Unal Egeli; Ahmet Bekar; Gulcin Tezcan; Elif Erturk; Nuran Bayram; Sahsine Tolunay
Journal:  Cell Mol Neurobiol       Date:  2011-09-18       Impact factor: 5.046

9.  Using a preclinical mouse model of high-grade astrocytoma to optimize p53 restoration therapy.

Authors:  Ksenya Shchors; Anders I Persson; Fanya Rostker; Tarik Tihan; Natalya Lyubynska; Nan Li; Lamorna Brown Swigart; Mitchel S Berger; Douglas Hanahan; William A Weiss; Gerard I Evan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-29       Impact factor: 11.205

10.  Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours.

Authors:  K Jacob; S Albrecht; C Sollier; D Faury; E Sader; A Montpetit; D Serre; P Hauser; M Garami; L Bognar; Z Hanzely; J L Montes; J Atkinson; J-P Farmer; E Bouffet; C Hawkins; U Tabori; N Jabado
Journal:  Br J Cancer       Date:  2009-07-14       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.